Amy Parsion Senior Vice President of Finance Amy Parison Appointed CFO Erick J. Lucera to Step Down as CFO to pursue another ...

Editas Medicine (EDIT) announced CFO Erick Lucera is stepping down to pursue an external opportunity, effective March 28. Current senior VP of ...

Erick J. Lucera to Step Down as CFO to pursue another opportunity Senior Vice President of Finance Amy Parison Appointed CFO CAMBRIDGE, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc.

So should Editas Medicine (NASDAQ:EDIT) shareholders be worried about its cash burn? For the purposes of this article, cash burn is the annual rate at which an unprofitable compan ...

Lucera, 57 years old, joins Dyne, a clinical-stage muscle disease company, from Editas Medicine, where he has served as CFO since May 2023, Dyne said Thursday. He has also held the top finance jobs at ...

CAMBRIDGE, Mass. - Editas Medicine, Inc. (NASDAQ:EDIT), a leader in gene editing technology with a market capitalization of $114 million, announced the departure of Chief Financial Officer Erick J.

Editas Medicine , Inc. (NASDAQ:EDIT), a leader in the biotechnology sector currently trading at $1.37 per share, announced a significant change in its executive team earlier this week. The company ...

Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has been given an average rating of “Hold” by the fourteen analysts that are currently covering the stock, MarketBeat reports. Two investment ...